Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

13

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

176872148

Full Text :

https://doi.org/10.1200/JCO.23.01911